Our highly efficient genome editing technology, CRISPR-SNIPER, was featured in the following article in “Bioradiations”. Title of the article: “Modernizing Gene Editing Detection with Droplet Digital PCR”
We are pleased to announce that our proposal has been selected by the Japan Agency for Medical Research and Development (AMED) for the third round of the “Research Project for Promoting Innovative Drug Development for Emerging and Re-emerging Infectious Diseases” in FY2022. The press release can be found here
We are pleased to announce that GenAhead Bio has been selected by the New Energy and Industrial Technology Development Organization (NEDO) as a recipient of the “Research and Development Start-up Support Program”. Click here for the press release.